• Return to Headlines

19.4% Return Seen to Date on SmarTrend Esperion Therape Call (ESPR)

By Nick Russo

SmarTrend identified an Uptrend for Esperion Therape (NASDAQ:ESPR) on November 18th, 2019 at $42.85. In approximately 2 weeks, Esperion Therape has returned 19.39% as of today's recent price of $51.16.

In the past 52 weeks, shares of Esperion Therape have traded between a low of $9.40 and a high of $57.38 and are now at $51.16, which is 444% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.4% while the 200-day MA has remained constant.

Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral and small molecule therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol and other cardio metabolic risk factors.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Esperion Therape shares.

Log in and add Esperion Therape (ESPR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights esperion therape

Ticker(s): ESPR